DNA-targeting molecules as therapeutic agents / edited by Michael J. Waring

Mitwirkende(r):

Waring, Michael J [HerausgeberIn]

Resource type: Ressourcentyp: Buch (Online)Buch (Online)Sprache: Englisch Reihen: Chemical biology ; no. 7Verlag: Cambridge : Royal Society of Chemistry, [2018]Copyright-Datum: © 2018Beschreibung: 1 Online-Ressource (xvii, 414 Seiten) : Illustrationen, DiagrammeISBN:

9781788012928
9781788012928
9781788014281

Schlagwörter:

Genre/Form:

Aufsatzsammlung

Andere physische Formen: 9781782629924 | Electronic version: DNA-targeting molecules as therapeutic agents. Cambridge : Royal Society of Chemistry, 2018 | Erscheint auch als: DNA-targeting molecules as therapeutic agents. Druck-Ausgabe. Cambridge : Royal Society of Chemistry, 2018DDC-Klassifikation:

615.8/95

LOC-Klassifikation:

RB155.8

DOI: DOI: 10.1039/9781788012928Online-Ressourcen:

Zugang im Netz des KIT

Zusammenfassung: Cover; Preface to Sequence-specific DNA Binding Agents; Preface; Contents; Chapter 1 DNA Recognition by Parallel Triplex Formation; 1.1 Why Triplexes?; 1.1.1 Triplets and Triplex Motifs; 1.1.2 Base, Sugar and/or Phosphate Modifications; 1.2 Stabilising Triplexes; 1.2.1 Enhancing Stacking and Hydrophobic Interactions; 1.2.2 Locking the Sugar Pucker; 1.2.3 Adding Positive Charge(s); 1.2.4 Removing Negative Charge(s); 1.2.5 Triplex-binding and Cross-linking Agents; 1.3 Decreasing pH Dependence; 1.3.1 Pyrimidine Analogues; 1.3.2 Purine Analogues; 1.4 Recognising Pyrimidine-Purine Base PairsZusammenfassung: 1.4.1 Null Bases and Abasic Linkers1.4.2 Natural Bases; 1.4.3 Analogues for CG Recognition; 1.4.4 Analogues for TA Recognition; 1.4.5 Other Approaches; 1.5 Towards Mixed Sequence Recognition at Neutral pH; 1.6 Outlook; Acknowledgements; References; Chapter 2 Interfacial Inhibitors; 2.1 Introduction; 2.2 Case Studies; 2.2.1 Topoisomerase Inhibitors; 2.2.2 HIV Integrase Strand Transfer Inhibitors; 2.2.3 STING Inhibitors; 2.2.4 Arp2-3 Inhibitors; 2.3 Prospects; Acknowledgements; References; Chapter 3 Slow DNA Binding; 3.1 Introduction-Kinetics vs. Thermodynamics of DNA BindingZusammenfassung: 4.2.1 Analysis of Tm shifts in the Presence of Drug4.2.2 Obtaining Binding Enthalpy Values by DSC; 4.2.3 Modeling Melting Curves by McGhee's Algorithm; 4.2.4 Case Studies: Bisintercalating Anthracyclines and Echinomycin; 4.2.5 Summary: Advantages and Pitfalls; 4.3 High-throughput Thermal Denaturation Approaches; 4.3.1 Differential Scanning Fluorimetry; 4.3.2 DSC Compared with DSF: Slow and Expensive but Definitive; 4.3.3 Illustrations of Differential Scanning Fluorimetry Data and Utility; 4.3.4 Advantages and Prospects; 4.4 Summary; Acknowledgements; ReferencesZusammenfassung: Chapter 5 Computer Simulations of Drug-DNA Interactions: A Personal Journey5.1 Introduction; 5.2 Minor Groove DNA Binders; 5.3 Natural Bifunctional Intercalators and Hoogsteen Base Pairing; 5.4 Bis-intercalation of Echinomycin and Related Bifunctional Agents in Relation to Binding Sequence Preferences; 5.5 Binding Preferences of Synthetic Pyridocarbazole Bis-intercalators; 5.6 Sequence Selectivity of Actinomycin D; 5.7 Binding of the Potent Antitumor Agent Trabectedin to DNA; 5.8 Other Examples of DNA Minor-groove-bonding Tetrahydroisoquinoline Antibiotics; 5.9 Melting DNA on the ComputerZusammenfassung: This book explains key aspects of the progress that has been made towards understanding how drugs can bind specifically to nucleic acids, and thus underpin the endeavour to make gene targeting a reality. The binding of drugs to DNA is a fast developing area of research with important applications in medicine, particularly the treatment of cancer. Early chapters cover methodologies to evaluate DNA-interactive agents and then the book provides examples of DNA-interactive molecules and technologies in development as therapeutic agents and treats in depth topics such as DNA-binding metal complexes, peptide and polyamide-DNA interactionsZusammenfassung: 3.2 Different DNA Binding Modes-Different DNA Binding Kinetics3.2.1 External Electrostatic Binding; 3.2.2 Groove Binding; 3.2.3 Intercalation; 3.2.4 Threading Intercalation; 3.3 Common Slow DNA Binders; 3.3.1 Actinomycin D; 3.3.2 Nogalamycin; 3.4 Ruthenium Complexes Exhibiting Slow DNA-binding Kinetics; 3.4.1 Bis-intercalating Ru-dimer [μ-c4(cpdppz)2(phen) 4Ru2]4+; 3.4.2 Semirigid Ru-dimer [μ-(11,11'-bidppz)(x)4Ru2]4+ (x=phen or bipy); 3.5 Addendum to Second Edition; References; Chapter 4 Thermal Denaturation of Drug-DNA Complexes; 4.1 Introduction; 4.2 Thermal Denaturation ToolsPPN: PPN: 1018828702Package identifier: Produktsigel: ZDB-1-RSEK

Exemplare ( 0 )

Dieser Titel hat keine Exemplare